Development of an Au/ZnO thin film surface plasmon resonance-based biosensor immunoassay for the detection of carbohydrate antigen 15-3 in human saliva

Clinical Biochemistry

Volumn 45, Issue 18, 2012, Pages 1689-1693

  Liang, Yang Hung ^a,b   Chang, Chia Chen ^a   Chen, Chien Cheng ^a   Chu Su, Yu ^a   Lin, Chii Wann ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Biacore SPR; Gold zinc oxide; Saliva carbohydrate antigen 15 3; Surface plasmon resonance

Indexed keywords

CARBOHYDRATE ANTIGEN; CARBOHYDRATE ANTIGEN 15-3; GOLD; UNCLASSIFIED DRUG; ZINC OXIDE;

ADULT; ARTICLE; BIOSENSOR; BREAST CANCER; CENTRIFUGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; IMMUNOASSAY; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; SALIVA ANALYSIS; SURFACE PLASMON RESONANCE;

ADULT; ANTIBODIES, IMMOBILIZED; CALIBRATION; FEMALE; GOLD; HUMANS; IMMUNOASSAY; MIDDLE AGED; MUCIN-1; SALIVA; SURFACE PLASMON RESONANCE; YOUNG ADULT; ZINC OXIDE;

EID: 84870712837     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2012.09.001     Document Type: Article

References (37)

1. Talal N. Sjogren's syndrome: historical overview and clinical spectrum of disease. Rheum Dis N Am 1992, 18:507-515.
2. Chatteron R.T., Vogelsong K.M., Lu Y.C., Ellman A.B., Hudgens G.A. Salivary alpha-amylase as a measure of endogenous adrenergic activity. Clin Physiol 1996, 16:433-448.
3. Tiwari S.K., Khan A.A., Ahmed K.S. Rapid diagnosis of Helicobacter pylori infection in dyspeptic patients using salivary secretion: a non-invasive approach. Singapore Med J 2005, 46:224-228.
4. Drobitch R.K., Svensson C.K. Therapeutic drug monitoring in saliva. An update. Clin Pharmacokinet 1992, 23:365-379.
5. Yang C.Y., Brooks E., Li Y., Danny P., Montemagno C.D. Detection of picomolar levels of interleukin-8 in human saliva by SPR. Lab Chip 2005, 5:1017-1023.
6. Bermejo-Pareja F., Antequera D., Vargas T., Molina J.A., Carro E. Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study. Neurology 2010, 10:1081-1087.
7. Boyle J.O., Mao L., Brennan J. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 1994, 168:429-432.
8. Warnakulasuriya S., Soussi T., Maher R., Johnson N., Tavassoli M. Expression of p53 in squamous cell carcinomas is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol 2002, 192:52-57.
9. Negri L., Pacchioni D., Calabrese F., Giacomasso S., Mastromatteo V. Serum and salivary CEA and GICA levels in oral cavity tumors. Int J Biol Markers 1988, 3:107-112.
10. Streckfus C., Bigler L. The use of soluble, salivary c-erbB-2 for the detection and post-operative follow-up of breast cancer in women: the results of a five-year translational research study. Adv Dent Res 2005, 18:17-24.
11. Hinestrosa M.C., Dickersin K., Klein P., Mayer M., Noss K., Slamon D., et al. Shaping the future of biomarker research in breast cancer to ensure clinical relevance. Cancer 2007, 7:309-315.
12. Streckfus C., Bigler L., Dellinger T., Dai X., Kingman A., Thigpen J.T. The presence of soluble c-erbB-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 2000, 6:2363-2370.
13. Agha-Hosseini F., Mirzaii-Dizgah I., Rahimi A. Correlation of serum and salivary CA15-3 levels in patients with breast cancer. Med Oral Patol Oral Cir Bucal 2009, 14:e521-e524.
14. Groschl M., Kohler H., Topf H., Rupprecht T., Rauh M. Evaluation of saliva collection devices for the analysis of steroids, peptides and therapeutic drugs. J Pharm Biomed Anal 2008, 47:478-486.
15. Atkinson K.R., Lo K.R., Payne S.R., Mitchell J.S., Ingram J.R. Rapid saliva processing techniques for near real-time analysis of salivary steroids and protein. J Clin Lab Anal 2008, 22:395-402.
16. Homola J. Present and future of surface plasmon resonance biosensors. J Anal Bioanal Chem 2003, 377:528-539.
17. Fu E., Chinowsky T., Miller J.W., Yanger P. SPR imaging-base salivary diagnostics system for the detection of small molecule analytes. Ann N Y Acad Sci 2007, 1098:335-344.
18. Haughey S.A., Campbell K., Yakes B.J., Prezioso S.M., DeGrasse S.L., Kawatsu K., et al. Comparison of biosensor platforms for surface plasmon resonance based detection of paralytic shellfish toxins. Talanta 2011, 85:519-526.
19. Rajan S.C., Gupta B.D. Surface plasmon resonance base fiber-optic sensor for the detection of pesticide. Sens. Actuators, B 2007, 123:661-666.
20. Stevens R.C., Soelberg S.D., Near S., Furlong C.E. Detection of cortisol in saliva with a flow-filtered, portable surface plasmon resonance biosensor system. Anal Chem 2008, 80:6747-6751.
21. Miyashita M., Shimada T., Miyagawa H., Akamatsu M. Surface plasmon resonance-based immunoassay for 17ß-estradiol and its application to the measurement of estrogen receptor-binding activity. Anal Bioanal Chem 2005, 381:667-673.
22. Chang C.C., Chiu N.F., Lin D.S., Chu-Su Y., Liang Y.H., Lin C.W. High-sensitivity detection of carbohydrate antigen 15-3 using a gold/zinc oxide thin film surface plasmon resonance-based biosensor. Anal Chem 2010, 82:1207-1212.
23. Chou S.F., Hsu W.L., Hwang J.M., Chen C.Y. Development of an immunosensor for human ferritin, a nonspecific tumor marker, based on surface plasmon resonance. Biosens Bioelectron 2004, 19:999-1005.
24. Karlsson R. SPR for molecular interaction analysis: a review of emerging application areas. J Mol Recognit 2004, 17:151-161.
25. BIA Technology handbook, version AB, Sweden 1998.
26. Henson B.T., Wang D.T. Collection, storage, and processing of saliva samples for downstream molecular application. Oral Biol Methods Mol Biol 2010, 666:21-30.
27. Helton K.L., Nelson K.E., Fu E., Yanger P. Conditioning saliva for use in a microfluidic biosensor. Lab Chip 2008, 8:1847-1851.
28. Babacan S., Pivarnik P., Letcher S., Rand A.G. Evaluation of antibody immobilization for piezoelectric biosensor application. Biosens Bioelectron 2000, 15:615-621.
29. Muñoz E., Vidarte L., Pastor C., Casado M., Vivanco F. A small domain of bacterial protein G inhibits C3 covalent binding to the Fc region of IgG immune complexes. Eur J Immunol 1998, 28:2591-2597.
30. BIAcore X100 handbook BR-1008-10 AB 1998, Sweden.
31. Liao H. Coupled whispering gallery modes in a multilayer-coated microsphere. Opt Lett 2003, 28:1970.
32. Wang X., Kong X., Yu Y., Zhang H. A highly efficient Ag-ZnO photocatalyst: synthesis, properties, and mechanism. J Phys Chem C 2007, 111:3836-3841.
33. Mosbacker H.L., Strzhemechny Y.M., White B.D., Smith P.E., Look D.C., Reynolds D.C., et al. Role of near-surface states in ohmic-Schottky conversion of Au contact to ZnO. J Appl Phys Lett 2005, 87:12102-12103.
34. Stenberg E., Persson B., Roos H., Urbaniczky C. Quantitative determination of surface concentration of protein with surface plasmon resonance using radiolabeled proteins. J Colloid Interface Sci 1991, 143:513.
35. Findlay J.W.A., Dillard R.F. Appropriate calibration curve fitting in ligand binding assays. AAPS J 2007, 9:E260-E267.
36. Schuck P. Reliable determination of binding affinity and kinetics using surface plasmon resonance biosensors. Curr Opin Biotechnol 1997, 8:498-502.
37. Yarmush M.L., Patankar D.B., Yarmush D.M. An analysis of transport resistances in the operation of BIAcore™; implications for kinetic studies of biospecific interactions. Mol Immunol 1996, 33:1203-1214.